Alkem Laboratories Limited (ALKEM) — Announcement
Alkem Laboratories announced its upcoming analyst and institutional investor meeting schedule on June 19, 2026, conducted virtually with Millennium Management. The filing confirms the meeting date but provides no financial results, guidance, or performance metrics, leaving investors without new operational or earnings insights. The notice emphasizes the virtual format and subject-to-change status without disclosing agenda details or participation requirements.
About Alkem Laboratories Limited (ALKEM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when ALKEM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ALKEM — Free💡 Ask AI about this filing
📊 More ALKEM filings
- 🔴 Corporate Action — 15 July 2026 Alkem Laboratories announced a shareholders' meeting on August 17, 2026, to approve a scheme of amal...
- Announcement — 1 July 2026 Alkem Laboratories disclosed favorable tax appeal orders from the Commissioner of Income Tax (Appeal...
- Announcement — 29 June 2026 Alkem Laboratories announced an upcoming analyst and institutional investor meeting scheduled for Ju...
- Announcement — 29 June 2026 Alkem Laboratories announced that its wholly owned subsidiary Alkem Medtech executed a First Supplem...
- Financial Results — 24 June 2026 Alkem Laboratories has announced that its trading window will close on 29 June 2026 and remain close...
🔥 Also filed on 15 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when ALKEM files new disclosures
Track ALKEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ALKEM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research